SEC Filing Summary for Aftab Blake - Adicet Bio, Inc.

This SEC filing details a transaction by Aftab Blake, Chief Scientific Officer of Adicet Bio, Inc. On June 19, 2026, Mr. Blake was granted 55,000 stock options to purchase the company's common stock at an exercise price of $8.10 per share. These options vest over 48 months, with 1/48th vesting monthly, contingent upon continued service and potential acceleration based on performance milestones. The filing, designated as Form 4, indicates that following this grant, Mr. Blake holds 55,000 shares under this option. The transaction is reported on June 23, 2026.